Expert Approach to Oncology Cases Softtissue: Sarcoma Recurrence

Patient Presentation & History

A 58-year-old male presents with a chief complaint of a progressively enlarging and painful mass in his right distal anterior thigh, noticed over the past three months.

His history is significant for a prior diagnosis of a high-grade pleomorphic undifferentiated sarcoma (PUS, previously classified as malignant fibrous histiocytoma) in the same anatomical location two years ago. At that time, he underwent a wide local excision (WLE) followed by adjuvant radiation therapy, completing 60 Gy in 30 fractions approximately 1.5 years prior to the current presentation.

The current mass is distinct from the original surgical scar but lies deep to it. He reports rapid growth of the mass, accompanied by increasing nocturnal pain that disrupts sleep. Functional limitations include mild difficulty with ambulation and stair climbing due to pain and the bulk of the mass. He denies any constitutional symptoms such as fever, unintentional weight loss, or night sweats.

His past medical history includes well-controlled hypertension on lisinopril and hyperlipidemia managed with atorvastatin. There is no history of other malignancies. Past surgical history is limited to the right distal thigh WLE for sarcoma. He has no known drug allergies. Socially, he is a non-smoker and reports occasional alcohol consumption. He is an accountant by profession. Family history is non-contributory for sarcomas or other hereditary cancer syndromes.

Clinical Examination

General: The patient is alert and oriented, appears to be in mild discomfort. His nutritional status is appropriate for his age and there are no signs of cachexia or systemic illness.

Inspection:
* A well-healed, linear longitudinal scar measuring approximately 15 cm is noted on the anteromedial aspect of the right distal thigh, consistent with his previous surgical intervention.
* A new, visibly protuberant soft tissue mass, estimated to be 8x6 cm, is observed deep to and slightly superior to the distal aspect of the previous scar. This mass causes localized skin tension but no overt skin breakdown, ulceration, or satellite lesions. There is subtle venous prominence over the mass, but no overt erythema.
* Mild, diffuse atrophy of the right quadriceps musculature is observed when compared to the contralateral limb, likely secondary to disuse and prior surgery/radiation.
* No obvious gross vascular or neurological deficits are apparent on initial inspection.

Palpation:
* The mass is palpable as a firm-to-hard, irregularly shaped, and poorly circumscribed lesion, approximately 8x6x5 cm. It is relatively immobile relative to the underlying femur but mobile in relation to the overlying skin. It is located primarily within the anterior compartment, deep to the previous scar, involving the region of the vastus medialis and intermedius.
* The mass is tender to palpation.
* There is mild warmth over the lesion, but no significant erythema or fluctuance, suggesting inflammation rather than acute infection.
* No palpable regional lymphadenopathy is detected in the right inguinal region; nodes are soft, small, and mobile if present.
* Neurovascular Assessment:
* Distal pulses (femoral, popliteal, dorsalis pedis, posterior tibial) are 2+ and symmetrical bilaterally, indicating intact major arterial flow. Capillary refill is brisk in both feet.
* Sensation is intact to light touch and pinprick in the L2-S1 dermatomes, bilaterally. No specific sensory deficit attributable to the mass is noted at this stage, though the saphenous nerve is anatomically close.
* Motor strength: Hip flexion, extension, abduction, and adduction are graded 5/5 bilaterally. Knee flexion is 5/5. Knee extension on the right is graded 4/5, likely limited by pain and the bulk of the mass impeding full quadriceps contraction; on the left, it is 5/5. Ankle dorsiflexion and plantarflexion are 5/5 bilaterally.

Range of Motion (ROM):
* Right Hip: Full and pain-free ROM in all planes (flexion, extension, abduction, adduction, internal/external rotation).
* Right Knee: Flexion is limited to 0-110 degrees (compared to 0-140 degrees on the contralateral side), with pain elicited at the end range due to the bulk of the mass and quadriceps involvement. Extension is full to 0 degrees, but end-range extension causes discomfort.
* Pain is specifically elicited and exacerbated with resisted knee extension, further implicating the quadriceps muscle group.

Imaging & Diagnostics

Initial Evaluation:

1. Plain Radiographs (AP & Lateral Right Femur and Knee):

   • Performed to assess for bony involvement, periosteal reaction, cortical erosion, or intralesional calcification.
   • Findings: In this case, plain radiographs show no overt cortical destruction, periosteal reaction, or intramedullary extension of the mass into the femur. No mineralization within the soft tissue mass. Surgical clips from the previous wide local excision are visible. This helps confirm that primary bone tumor or significant bone involvement is unlikely but does not rule out subtle cortical abutment or invasion.

2. Magnetic Resonance Imaging (MRI) of the Right Thigh with and without Gadolinium Contrast:

   • The definitive imaging modality for soft tissue sarcoma, crucial for local staging, surgical planning, and assessing neurovascular relationships. It delineates the exact anatomical extent of the tumor.
   • Findings: A large (e.g., 8.5 cm cranio-caudal x 6.2 cm anterior-posterior x 5.8 cm medio-lateral), heterogeneously T1-hypointense and T2-hyperintense soft tissue mass is identified deep to the prior surgical bed. The mass demonstrates avid, heterogeneous enhancement post-gadolinium administration, with central areas of non-enhancement suggestive of necrosis or hemorrhage.
   • It involves the vastus medialis and intermedius muscles, extending into the anterior compartment. The superior aspect of the mass demonstrates intimate contact with the superficial femoral artery and vein, as well as the saphenous nerve, with evidence of early adventitial encasement of the artery over a short segment (e.g., 2 cm). The adductor magnus and sartorius muscles appear compressed but not directly invaded.
   • The mass abuts the anterior cortex of the mid-distal femur; however, there is no definitive cortical breach or intramedullary extension, although periosteal reaction is noted, suggesting adherence.
   • Significant peritumoral edema is observed in the surrounding muscle planes. No clear skip lesions are identified proximally or distally in the thigh. Metallic surgical clips from the previous procedure are visualized within the scar tissue.

3. Computed Tomography (CT) of the Chest, Abdomen, and Pelvis (with Intravenous Contrast):

   • Essential for comprehensive metastatic workup, as lung is the most common site for distant metastasis in soft tissue sarcomas.
   • Findings: No pulmonary nodules suggestive of metastatic disease are identified in the chest. No liver lesions, retroperitoneal lymphadenopathy, or other abdominal/pelvic metastases are seen. This confirms an M0 disease status at present.

4. PET/CT (Positron Emission Tomography/Computed Tomography):

   • Increasingly utilized in sarcoma staging and recurrence surveillance. While MRI provides superior anatomical detail, PET/CT offers functional information regarding metabolic activity.
   • Findings: The recurrent thigh mass demonstrates intense FDG avidity with a high maximum standardized uptake value (SUVmax > 8.0), characteristic of a high-grade malignancy. No other sites of abnormal FDG uptake are identified, corroborating the absence of distant metastases from the CT scan. This helps confirm the malignant nature and high metabolic activity of the recurrent lesion.

Biopsy:

• Previous Biopsy (2 years prior): Incisional biopsy confirmed high-grade pleomorphic undifferentiated sarcoma.
• Current Biopsy (Mandatory for Recurrence): Given the clinical suspicion of recurrence and the prior history of high-grade disease, a new image-guided (ultrasound or CT-guided) core needle biopsy is mandatory . This is critical to confirm the recurrence, reassess tumor grade, and evaluate for any dedifferentiation, which could alter management. The biopsy tract must be carefully planned to ensure it can be excised en-bloc with the definitive surgical specimen, preventing tumor seeding.
  • Histopathology (Current): Examination of the core biopsy specimens confirms a recurrent high-grade pleomorphic undifferentiated sarcoma. High cellularity, significant nuclear pleomorphism, numerous atypical mitotic figures (e.g., >10 mitotic figures per 10 high-power fields), and areas of geographical necrosis are present. Immunostains (e.g., negative for S100, desmin, cytokeratins, CD34, consistent with PUS) confirm the diagnosis. The grade remains high, similar to the initial presentation. No evidence of specific translocations or molecular markers for targeted therapy (often absent in PUS).

Templating:
* Based on detailed MRI and CT findings, surgical templating involves:
* Precise mapping of the tumor dimensions and its relationship to the femoral neurovascular bundle (superficial femoral artery/vein, femoral nerve branches, saphenous nerve), the femur, and knee joint.
* Planning for wide margins (aiming for ≥2 cm for high-grade sarcomas) considering the previous surgical bed and radiation field. This necessitates resecting portions of the vastus medialis and intermedius muscles.
* Assessing the resulting soft tissue defect and planning for potential reconstructive options, such as a local or free flap (e.g., anterolateral thigh flap, latissimus dorsi free flap) in conjunction with a plastic surgeon, given the size of the anticipated defect and prior radiation.
* Considering the need for segmental vascular resection and reconstruction if definitive involvement of the superficial femoral vessels is confirmed intraoperatively.

Differential Diagnosis

The presentation of a rapidly growing, painful mass in a previously treated sarcoma field necessitates a structured differential diagnosis.

Surgical Decision Making & Classification

Rationale for Operative Intervention:
The definitive diagnosis of recurrent high-grade pleomorphic undifferentiated sarcoma necessitates aggressive surgical management. Local control is the cornerstone of treatment for sarcomas and is paramount for both limb salvage and overall survival. Non-operative management would invariably lead to uncontrolled local disease progression, rapid increase in tumor burden, potential for neurovascular compromise, and ultimately render the limb unsalvageable while increasing the risk of distant metastasis. Given the patient's good performance status, the absence of distant metastatic disease (M0), and the resectability of the lesion demonstrated on imaging, a curative-intent resection is the appropriate course of action.

Challenges of Recurrence:
Recurrent sarcomas present significant surgical challenges:
1. Altered Anatomy: Previous surgery, scar tissue, and radiation-induced fibrosis significantly distort normal tissue planes, making dissection difficult and increasing the risk of iatrogenic injury.
2. Increased Aggressiveness: Recurrent lesions may be biologically more aggressive, with a higher propensity for local spread and distant metastasis.
3. Compromised Tissues: Prior radiation therapy impairs wound healing, increases the risk of infection, and makes achieving wide, healthy soft tissue margins more difficult.
4. Neurovascular Involvement: Recurrent tumors often abut or involve critical neurovascular structures due to scar tissue tethering or tumor growth along fascial planes.

Staging (AJCC 8th Edition for Soft Tissue Sarcoma of Extremity/Trunk):
* T (Tumor Size): T2b (Tumor size > 5 cm, deep to superficial fascia).
* N (Regional Lymph Nodes): N0 (No regional lymph node metastasis).
* M (Distant Metastasis): M0 (No distant metastasis).
* G (Histologic Grade): G3 (High-grade, based on histology, mitotic rate, and necrosis).
* Pathological Stage Group: Based on these parameters, the patient's recurrent tumor is classified as Stage III (High-grade, >5cm, deep, M0). This aggressive staging underscores the need for radical local treatment.

Limb Salvage vs. Amputation:
Based on the detailed MRI findings, the recurrent mass, while intimately associated with the superficial femoral neurovascular bundle and abutting the femur, appears technically resectable with achievable wide margins while preserving critical neurovascular structures and leading to a functional limb. The patient's strong desire for limb preservation, coupled with the absence of unequivocal vascular encasement requiring extensive reconstruction or irreparable nerve damage, supports a limb salvage approach. Amputation would be considered a necessary option if:
1. Achieving negative (R0) margins would invariably lead to an unsalvageable neurovascular bundle.
2. The resulting limb would be non-functional (e.g., flail limb, severe contracture).
3. There is extensive bone invasion beyond periosteal involvement that would necessitate massive prosthetic replacement beyond the scope of a functional limb.

Multidisciplinary Tumor Board (MDTB) Discussion:
An MDTB discussion is indispensable for all sarcoma cases, particularly for recurrences. Key attendees include Orthopedic Oncologist, Medical Oncologist, Radiation Oncologist, Musculoskeletal Radiologist, Pathologist, and often a Plastic Surgeon.
* Key Discussions:
* Confirmation of the diagnosis and accurate staging.
* Optimal surgical plan to achieve R0 resection, considering the complexity of prior surgery and radiation.
* The role of neoadjuvant therapy: Given the prior definitive radiation, re-irradiation is highly complex and carries significant risks of toxicity (e.g., severe wound healing issues, fibrosis, necrosis). It would only be considered in highly selected cases with advanced techniques (e.g., proton therapy, brachytherapy) and requires careful risk-benefit analysis. Neoadjuvant chemotherapy, while sometimes used for high-grade sarcomas, has less clear benefit for PUS and could delay definitive local control in a rapidly growing recurrence. For this patient, immediate surgical resection is prioritized.
* Anticipated need for complex soft tissue reconstruction (e.g., local or free flap).
* Post-operative adjuvant therapy plan, tailored to the definitive pathology findings.

Surgical Goal:
The primary surgical goal is en-bloc wide (R0) excision of the recurrent tumor, encompassing the original biopsy tract and previous surgical scar, within a generous cuff of healthy tissue, while simultaneously preserving maximal limb function. This involves meticulous dissection to achieve negative microscopic margins.

Consent:
A thorough discussion with the patient is undertaken regarding the complexity of the procedure, including potential intraoperative and postoperative complications: neurovascular injury (e.g., vascular compromise requiring bypass, nerve palsy, sensory deficits), wound dehiscence, infection, flap failure, deep vein thrombosis, pulmonary embolism, chronic pain, and significant functional deficits (e.g., quadriceps weakness, knee flexion contracture). The possibility of requiring further surgical intervention or, in rare circumstances, secondary amputation if limb salvage is compromised oncologically or functionally, is also explicitly discussed.

Surgical Technique / Intervention

Pre-operative Planning:
* Detailed review of all imaging, especially the MRI, to precisely map the tumor's extent, its relationship to the femoral neurovascular bundle (superficial femoral artery and vein, femoral nerve branches, saphenous nerve), adjacent muscle compartments, and the femur.
* Careful planning of the incision, anticipated resection margins, and potential reconstructive options.
* Pre-operative vascular mapping (e.g., CT angiography) if the tumor's proximity to major vessels suggests potential encasement or need for vascular reconstruction.
* A plastic surgeon is consulted and coordinated with, given the anticipated large soft tissue defect and the need for complex flap reconstruction in a previously irradiated field.

Patient Positioning:
* The patient is positioned supine on the operating table.
* The affected right lower limb is abducted and externally rotated, supported by a leg holder or beanbag, to ensure comprehensive access to the anteromedial and medial aspects of the thigh.
* The limb and ipsilateral iliac crest (for potential free flap donor site) are prepped and draped widely from the iliac crest to the foot.
* A tourniquet is placed high on the thigh but not inflated initially, as meticulous vascular control during dissection is preferred to avoid obscuring tumor planes; it is kept as a contingency for severe hemorrhage.

Surgical Approach:
* The previous longitudinal surgical incision on the anteromedial thigh is incorporated into a new, wider elliptical incision. This incision is designed to encompass the palpable recurrent mass, the entire previous scar, and the biopsy tract with a generous cuff of healthy skin and subcutaneous tissue.
* Skin and subcutaneous flaps are raised carefully in the superficial plane to expose the deep fascia overlying the muscle compartments. Care is taken to stay superficial to the deep fascia until healthy tissue planes are identified.

Tumor Resection (En-bloc Wide Excision):
* Dissection proceeds systematically, establishing healthy tissue planes outside the anticipated tumor boundaries, working from healthy, uninvolved tissue towards the tumor.
* Identification and Protection of Neurovascular Structures: Meticulous and painstaking dissection is initiated to identify and protect the critical neurovascular structures, including the superficial femoral artery and vein, and the branches of the femoral nerve. The saphenous nerve, often intimately associated with the tumor in this region, is identified. Given its sensory nature and the need for oncologic clearance, a decision is made to sacrifice the saphenous nerve if it is definitively involved or impinges on achieving a negative margin. Motor nerves are meticulously preserved.
* Intraoperative Finding: The superficial femoral artery and vein are found to be densely adherent to the superior margin of the tumor due to scar and recurrent disease. Careful adventitial dissection is performed, creating a plane between the vessel and the tumor capsule, without compromising the vessel wall, thereby allowing their preservation. If true mural invasion or circumferential encasement were encountered, segmental vascular resection and interposition grafting (e.g., saphenous vein graft or prosthetic graft) by a vascular surgeon would be necessary.
* Muscle Resection: The vastus medialis and intermedius muscles, confirmed to be involved by the tumor on MRI and intraoperatively, are resected en-bloc with the tumor. The dissection extends deeply to the periosteum of the femur.
* Deep Margin: The tumor abuts the anterior cortex of the femur. To ensure a clear deep margin, the periosteum overlying the involved segment of the femur is sharply elevated and resected en-bloc with the specimen. While full cortical or intramedullary invasion is not evident, taking the periosteum ensures the deepest margin is clear.
* Proximal and Distal Margins: Adequate length margins (e.g., 5-7 cm of grossly normal muscle and fascia) from the palpable tumor edge are achieved, necessitating a segmental resection of the involved quadriceps muscle belly.
* Specimen Orientation: The resected specimen, encompassing the recurrent tumor, previous biopsy tract, and surrounding healthy tissue, is meticulously oriented with sutures or surgical clips (e.g., a long suture for the superior margin, a short suture for the medial margin). This allows the pathologist to accurately assess all resection margins. The specimen is immediately sent for histopathological evaluation with specified inked margins.
* Intraoperative Margin Assessment (Frozen Section): While not routinely relied upon for definitive sarcoma margins due to the complexity of soft tissue pathology, frozen section analysis of any grossly suspicious margins, especially where anatomical constraints prevent further resection (e.g., near femoral nerve), may be considered. In this case, gross margins appear clear.

Reconstruction:
* A significant soft tissue defect remains following the quadriceps muscle resection. Primary closure would lead to excessive tension, potential wound dehiscence, and severe functional impairment.
* Soft Tissue Coverage: Given the large defect and the prior radiation therapy (which compromises local tissue for primary closure or local flaps), a pedicled anterolateral thigh (ALT) free flap is planned in conjunction with the Plastic Surgery team. The ALT flap provides robust, vascularized tissue to fill the dead space and provide durable soft tissue coverage.
* The ALT flap is harvested from the ipsilateral thigh, ensuring careful preservation of its vascular pedicle (perforators from the descending branch of the lateral circumflex femoral artery).
* Microvascular anastomosis is performed between the flap pedicle vessels and recipient vessels (e.g., branches of the superficial femoral artery/vein) in the defect zone.
* Dead Space Management: Multiple closed suction drains (e.g., Jackson-Pratt drains) are placed within the surgical bed prior to flap inset and closure to prevent seroma or hematoma formation, which could compromise flap viability.

Wound Closure:
* The ALT flap is meticulously secured to the recipient site, ensuring even tension and optimal contour.
* Layered closure of the donor site and the recipient site is performed using absorbable sutures for deep layers and non-absorbable sutures or staples for the skin.
* Sterile dressings are applied.

Post-Operative Protocol & Rehabilitation

Immediate Post-Operative Period (Days 0-7):
* Pain Management: Multimodal analgesia regimen including intravenous opioids, NSAIDs (if not contraindicated), gabapentinoids, and consideration of continuous peripheral nerve blocks (e.g., femoral nerve block) to optimize pain control and facilitate early mobilization.
* Wound and Flap Monitoring: Hourly monitoring of the free flap for color, turgor, temperature, and capillary refill to detect any signs of vascular compromise (ischemia or venous congestion). Continuous doppler monitoring of flap vessels may be utilized. Drains are meticulously monitored for output volume and character. The limb is elevated to minimize swelling.
* DVT Prophylaxis: Pharmacological (e.g., low molecular weight heparin) and mechanical (e.g., sequential compression devices) deep vein thrombosis prophylaxis is initiated.
* Antibiotics: Prophylactic broad-spectrum intravenous antibiotics are continued for 24-48 hours post-operatively.
* Mobility: Strict bed rest with the limb elevated is maintained for the initial 3-5 days to ensure flap viability and minimize tension. Gentle, passive range of motion (ROM) exercises for the knee and hip are commenced only under therapist guidance, avoiding any tension across the surgical site or flap.
* Weight Bearing: Non-weight-bearing (NWB) or touch-down weight-bearing (TDWB) with crutches is prescribed for the initial 2-4 weeks, depending on flap integration and wound healing progress.

Early Rehabilitation (Weeks 2-6):
* Physical Therapy (PT) / Occupational Therapy (OT):
* Gradual increase in active-assisted and active ROM exercises for the knee and hip. The goal is to regain knee extension and flexion, cautiously avoiding overstretching the flap or surgical site.
* Isometric quadriceps contractions are initiated, progressing to gentle resistive exercises as tolerated and as wound healing permits.
* Scar management techniques (massage, silicone sheeting) are started once the wound is stable to prevent adhesions and contractures.
* Gait training progresses from NWB/TDWB to partial weight-bearing (PWB) and eventually full weight-bearing (FWB) with assistive devices, typically after 4-6 weeks, based on surgeon's discretion and tissue healing.
* Emphasis on restoring quadriceps strength and function, which will be significantly impacted by muscle resection and flap reconstruction.

Late Rehabilitation (Weeks 6+ to Months):
* Strengthening: Progressive resistance training for the entire lower extremity, focusing on the quadriceps, hamstrings, and hip musculature.
* Proprioception and Balance Training: Exercises to improve balance and stability, crucial for return to functional activities.
* Functional Training: Gradual reintroduction to activities of daily living (ADLs), work-related tasks, and eventually recreational activities.
* Cardiovascular Conditioning: General fitness and endurance training are encouraged.
* Potential Challenges: Expected residual quadriceps weakness, potential for knee flexion contracture, localized lymphedema, chronic pain (including neuropathic pain if the saphenous nerve was sacrificed), and potential sensory deficits in the medial thigh/leg. Intensive, long-term physical therapy is crucial to mitigate these challenges and maximize functional recovery.

Adjuvant Therapy:
* Medical Oncology: Following definitive pathology and a clear surgical margin, a medical oncologist will re-evaluate the patient. Given the high-grade nature and recurrence of the sarcoma, adjuvant systemic chemotherapy (e.g., doxorubicin-based regimens) may be discussed, despite its controversial role in adult PUS, especially for high-risk features like large size, high grade, and deep location. The patient's prior radiation precludes further local radiotherapy in most circumstances.
* Radiation Oncology: Re-irradiation to the surgical bed is generally avoided due to the high risk of cumulative radiation toxicity (severe wound complications, bone necrosis, chronic lymphedema, secondary malignancy). It would only be considered in the case of truly positive (R1/R2) surgical margins, after extensive multidisciplinary discussion, and potentially utilizing highly conformal techniques (e.g., brachytherapy, proton therapy) to spare surrounding critical structures. In this case, with presumed R0 margins, further radiation is unlikely.

Follow-up:
* Clinical Surveillance: Regular clinical examinations every 3 months for the first 2 years, then every 6 months for the subsequent 3 years, and annually thereafter. This involves careful palpation of the surgical site and regional lymph nodes.
* Imaging Surveillance:
* MRI of the surgical site every 6 months for 3 years, then annually, to detect any local recurrence.
* CT chest every 6-12 months for 3-5 years, then annually, to screen for pulmonary metastases, which represent the most common site of distant failure for high-grade sarcomas. Abdominal/pelvic imaging may be included as indicated.

Pearls & Pitfalls (Crucial for FRCS/Board Exams)

Pearls:

• Mandatory Multidisciplinary Team Discussion: All sarcoma cases, particularly recurrences, must be presented and discussed at a dedicated Musculoskeletal Tumor Board. This ensures a comprehensive treatment plan, optimal patient outcomes, and adherence to evidence-based guidelines.
• Planned Biopsy: Never proceed with definitive resection without a clear, specific histological diagnosis from a properly executed core needle biopsy. The biopsy tract must be within the planned resection field and excised en-bloc with the tumor to prevent tumor seeding.
• MRI is the Gold Standard for Local Staging: It provides exquisite soft tissue detail, delineating tumor extent, relationship to neurovascular structures and bone, and is indispensable for surgical planning and margin assessment. Ensure the MRI encompasses the joint above and below the lesion.
• Achieving R0 (Microscopically Negative) Margins is Paramount: This is the strongest prognostic factor for local control and recurrence-free survival in sarcoma surgery. Aim for gross margins of 2-3 cm for high-grade sarcomas.
• Anatomical Compartmental Resection: Where anatomically feasible, perform a compartmental resection to ensure oncologically sound margins. This involves resecting the entire muscle or fascial compartment involved.
• Balance Oncologic Principles with Functional Preservation: While limb salvage is desirable, it must never compromise oncologic safety. A non-functional limb with positive margins is a poor outcome.
• Aggressive Metastatic Workup: A comprehensive metastatic workup (CT chest/abdomen/pelvis, potentially PET/CT) is mandatory prior to definitive local treatment to exclude distant disease.
• Neurovascular Consideration: Be prepared for meticulous neurovascular dissection. If major vessels are truly involved, be ready for segmental resection and vascular reconstruction in conjunction with a vascular surgeon. Non-essential nerves (e.g., saphenous nerve in the thigh) may need to be sacrificed for oncologic clearance.
• Early Plastic Surgery Involvement for Reconstruction: Anticipate the need for complex soft tissue reconstruction (e.g., local or free flaps), especially in large defects or previously irradiated fields. Early consultation with a plastic surgeon is crucial for planning.
• Post-operative Surveillance: High-grade sarcomas carry a significant risk of both local recurrence and distant metastasis. A rigorous, long-term follow-up protocol with clinical examination and cross-sectional imaging (MRI locally, CT chest) is essential.

Pitfalls:

• Inadequate or Misplaced Biopsy: A poorly performed biopsy (e.g., excisional biopsy through normal tissue, biopsy tract not excisable) can lead to tumor contamination, positive margins, and compromise limb salvage.
• Incomplete Staging: Failing to rule out distant metastases before embarking on aggressive local surgery can lead to futile interventions and inappropriate treatment plans.
• Underestimating Tumor Extent: Relying solely on clinical palpation or inadequate imaging can lead to positive margins and local recurrence. MRI provides the true anatomical extent.
• Compromising Oncologic Margins for Functional Preservation: This is a critical error in sarcoma surgery. Sacrificing wide margins to preserve a non-essential structure or achieve a slightly better functional outcome significantly increases the risk of local recurrence and negatively impacts survival.
• Ignoring the Effects of Prior Radiation: Previously irradiated tissue has compromised vascularity, reduced healing potential, and altered tissue planes. This significantly increases the risk of wound complications, infection, and makes dissection more challenging.
• Lack of Multidisciplinary Input: Proceeding with complex sarcoma surgery without the collective wisdom and expertise of a dedicated MDTB is a major pitfall and can lead to suboptimal decision-making and patient care.
• Failure to Discuss Amputation as an Option: While limb salvage is the primary goal, failing to present amputation as a necessary option when oncologic safety cannot be achieved with limb salvage, or when limb salvage would result in a non-functional or painful limb, is a disservice to the patient.
• Assuming Benignity: Any deep-seated, rapidly growing, or painful soft tissue mass in an adult, especially with a history of malignancy, must be managed with a high index of suspicion until proven benign by definitive biopsy.
• Inadequate Post-operative Rehabilitation: Neglecting intensive and tailored post-operative physical therapy can lead to poor functional outcomes, contractures, and chronic pain, even with a technically successful surgery.